Ciba Rescula For Glaucoma Will Have DTC Print Ads At September Launch
Novartis subsidiary Ciba Vision is preparing direct-to-consumer print ads for a Sept. 18 launch of its second-line glaucoma therapy Rescula.
You may also be interested in...
Novartis Rx Exec Changes Include U.S. COO Epstein To Oncology Unit Head
Novartis Pharmaceutical U.S. Chief Operating Officer David Epstein will head the Swiss company's new global oncology business unit effective Sept. 1.
Xalatan (latanoprost) and timolol (Merck's Timoptic and generics) combination product deemed "approvable" June 2 for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers. The application was submitted during the fourth quarter of 1999 and is under priority review. Pharmacia currently markets Xalatan for open-angle glaucoma and ocular hypertension
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011